Webinar: Advancing Clinical Research Through Hybrid Clinical Trials and Patient Optionality

by EmVenio | Aug 20, 2024 | Webinar

Discover an informative webinar that revolutionizes the impact of hybrid clinical trials by implementing patient-centric solutions that fast-track the development of life-changing therapies. Historically, trials necessitated in-person participation,...

EmVenio’s clinical research sites at Prime Healthcare hospitals now open in Dallas and Atlanta

by EmVenio | Aug 1, 2024 | Press Release

Pre-study visits now available for clinical research organizations and trial sponsors DURHAM, N.C., Aug. 1, 2024 /PRNewswire/ — EmVenio Research announced today it has opened two dedicated research centers within the Prime Healthcare hospital...

PCM Trials and EmVenio Research Announce the Appointment of Jeff Huntsman as Chief Commercial Officer

by EmVenio | Jul 23, 2024 | Press Release

Denver, CO., July 23, 2024 – PCM Trials and EmVenio Research, a PCM Trials Company are pleased to announce the addition of Jeff Huntsman to the leadership team as Chief Commercial Officer. Jeff brings over 30 years of experience in commercial planning, global business...

EmVenio Research Commits to SCRS Global Impact Partner Program

by EmVenio | Jun 6, 2024 | Blog

June 6th, 2024 – The Society for Clinical Research Sites (SCRS) proudly announces the addition of EmVenio Research to its Global Impact Partner (GIP) Program. EmVenio, a PCM Trials company, is part of the largest independent decentralized clinical trial (DCT) site...

EmVenio Research’s May 2024 Community Engagement Highlights

by EmVenio | May 31, 2024 | Blog

Our collaboration with local organizations creates opportunity to address critical health issues and topics through the lens of clinical research, promoting wellness, and bringing value to the communities we serve. The well-being of our communities remains at the...